Task: Answer the MCQ question.
Question: Which compound exhibits a 1.409\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCN(CC)CCOC(=O)c1ccc(N/C=C(/C#N)c2nc(-c3cccc(OC)c3)cs2)cc1
b.) CCCn1c(C(C)Nc2nc(-c3cccc(Br)c3)cs2)nc2ccccc21
Answer: b. CCCn1c(C(C)Nc2nc(-c3cccc(Br)c3)cs2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(C(C)Nc2nc(-c3cccc(Br)c3)cs2)nc2ccccc21
CCCn1c(C(C)Nc2nc(-c3cccc(Br)c3)cs2)nc2ccccc21
4-(3-bromophenyl)-N-[1-(1-propylbenzimidazol-2-yl)ethyl]-1,3-thiazol-2-amine